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Background: Granzyme B (GrzB) is a serine proteinase expressed by memory T cells and NK cells. Methods to measure
GrzB protein usually involve intracellular (flow cytometry) and extracellular (ELISA and ELISpot) assays. CD8 T cells are
the main source of GrzB during immunological reactions, but activated CD4 T cells deploy GrzB as well. Because GrzB is
an important mediator of cell death, tissue pathology and disease, clarification of differences of GrzB expression and
secretion between CD4 and CD8 T cells is important for understanding effector functions of these cells.
Results: Memory CD4 and memory CD8 T cells were purified from human peripheral blood of healthy donors, and
production of GrzB was directly compared between memory CD4 and memory CD8 T cells from the same donors
using parallel measurements of flow cytometry (intracellular GrzB), ELISpot (single cell secretion of GrzB), and ELISA
(bulk extracellular GrzB). Memory CD8 T cells constitutively stored significantly more GrzB protein (~25%) compared to
memory CD4 T cells as determined by flow cytometry (~3%), and this difference remained stable after 24 hrs of
activation. However, measurement of extracellular GrzB by ELISA revealed that activated memory CD4 T cells secrete
similar amounts of GrzB (~1,000 pg/ml by 1x105 cells/200 μl medium) compared to memory CD8 T cells (~600 pg/ml).
Measurement of individual GrzB-secreting cells by ELISpot also indicated that similar numbers of activated memory
CD4 (~170/1x105) and memory CD8 (~200/1x105) T cells secreted GrzB. Expression of CD107a further indicated that
Grzb is secreted similarly by activated CD4 and CD8 T cells, consistent with the ELISA and ELISpot results. However,
memory CD8 T cells expressed and secreted more perforin compared to memory CD4 T cells, suggesting that perforin
may be less associated with GrzB function for memory CD4 T cells.
Conclusions: Although measurement of intracellular GrzB by flow cytometry suggests that a larger proportion of CD8
T cells have higher capacity for GrzB production compared to CD4 T cells, ELISpot and ELISA show that similar
numbers of activated CD4 and CD8 T cells secrete similar amounts of GrzB. Secretion of GrzB by activated CD8
T cells may be more tightly controlled compared to CD4 T cells.
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Granzyme B (GrzB) is a serine proteinase important for
its role in mediating cellular apoptosis as well as acting
as an extracellular protease. GrzB is expressed primarily
by activated memory CD8 and memory CD4 T cells, and
NK and NKT cells during infections and inflammation.* Correspondence: Dorothy.E.Lewis@uth.tmc.edu
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unless otherwise stated.Other leukocytes such as dendritic cells, macrophages, B
cells, and mast cells can express GrzB but such expres-
sion is more limited [1-5]. GrzB is upregulated in CD8
T cells after CD3/TCR activation, as well as by common
γ-chain cytokines including IL2 and IL15. In memory
and effector CD4 T cells, Treg, Th1, and Th17 cells,
GrzB is also induced after TCR activation and similar
cytokines, as well as by TLR ligands [6,7]. Similarly to
memory CD8 T cells, memory CD4 T cells also kill
virally-infected or tumor cells via GrzB [8-10]. GrzB ex-
pression and bioactivity appears to be comparable
amongst CD4 and CD8 T cells, but no studies have. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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CD4 and CD8 T cells. Differences in GrzB expression,
storage, and secretion suggest that GrzB functions may
differ between CD4 and CD8 T cells in immunity and
disease.
Studies examining expression and functional activity
of GrzB or GrzB-associated molecules such as perforin
or CD107a (LAMP-1) in CD4 and CD8 T cells utilize
mainly western blot, flow cytometry, and CTL killing as-
says. For example, previous comparison of GrzB expres-
sion in human CD4 and CD8 T cells by flow cytometry
showed that CD8 T cells express more intracellular GrzB
protein, however, comparison of extracellular GrzB be-
tween CD4 and CD8 T cells was not examined [11]. Our
previous work directly compared human memory CD4
and memory CD8 T cells by flow cytometry and we
found that resting and activated memory CD4 T cells
store little to no GrzB protein intracellularly, whereas
resting and activated memory CD8 T cells store substan-
tially more GrzB [12]. However, ELISA showed that acti-
vated memory CD4 and memory CD8 T cells secreted
similar amounts of GrzB. In another study, using im-
mortalized human HSV- and EBV-specific CD4 CTL
clones, CD8 CTL’s were shown to express significantly
more perforin mRNA compared to CD4 CTL’s, and tar-
get cell killing was similar between CD4 and CD8 CTL’s
(although GrzB was not examined) [13]. In a mouse
model of LCMV infection, direct comparison of antigen-
specific CD4 and CD8 CTL’s by flow cytometry showed
that CD8 T cells express more GrzB and CD107a. How-
ever, in vivo CTL killing measurements showed that
CD4 T cells eliminate target cells with comparable effi-
ciency and magnitude as CD8 T cells [14,15]. Thus, CD4
and CD8 T cells may differ in GrzB synthesis, storage
and secretion, but clarification of discrepancies between
methods to measure intracellular and extracellular GrzB
is necessary to better understand the roles of GrzB in ef-
fector functions and tissue pathology mediated by CD4
T cells.
The goal of the present study was to directly compare
GrzB production by human memory CD4 and memory
CD8 T cells (ie. purified from the same donor and stud-
ied in parallel) with the common assays of flow cytome-
try, ELISpot, and ELISA. Each of these gives different
information about the effector function of a T cell. Flow
cytometry indicates the intracellular content of single
cells, and ELISpot measures how much is secreted from
individual cells and is thus conceptually similar to flow
cytometry measurement. Lastly, ELISA indicates how
much GrzB is secreted globally, but does not indicate
how many cells the material came from. Our studies
seek to clarify differences of intracellular GrzB expres-
sion vs. actual secretion by memory T cells. Differences
in GrzB protein storage and secretion were observedbetween resting and activated memory CD4 and mem-
ory CD8 T cells. Activated memory CD4 T cells usually
secreted similar amounts of GrzB compared to memory
CD8 T cells (ELISpot and ELISA), despite memory CD8
T cells storing significantly more GrzB as indicated by
flow cytometry. Thus, activated memory CD4 T cells are
major sources of extracellular GrzB, and the use of flow
cytometry or western blot alone to measure intracellular
GrzB does not accurately predict secretion levels.
Methods
Cells and culture
Human memory CD4+CD45RO+ and memory CD8+
CD45RO+ T cells were purified from PBMC of healthy
buffy coat donors. PBMC were first isolated from buffy
coats (Gulf Coast Regional Blood Center, Houston, TX)
by using Ficoll-Paque PLUS (GE Healthcare). Memory
CD4 and memory CD8 Tcells were then negatively selected
from PBMC with magnetic bead-based EasySep kits (Stem-
cell Technologies). Purities of memory CD4+CD45RO+
T cells were usually >90% and memory CD8+CD45RO+
T cells >80% as determined by flow cytometry. Natural
killer cells were purified from PBMC with negative se-
lection kits (Stemcell Technologies), and CD3-CD56+
purity was >90%. Cells were cultured at 37°C + 5%CO2
in complete RPMI-1640 medium, supplemented with
10% FBS, 0.1 mM MEM nonessential amino acids, 2mM
sodium pyruvate, 2mM HEPES, 1× antibiotic-antimycotic
and 2mM L-glutamine.
Most experiments involved no stimulation (UT) or
stimulation of 1-5×105 memory CD4 and memory CD8
T cells, or NK cells (200 μl/well of 96-well flat-bottom
plates, or 1 ml/well of 24-well plates, as indicated) for 24
hrs with 1 ml/ml coated CD3 (clone UCHT1, BD Biosci-
ences) or soluble CD3 (clone CD3-2, Mabtech) + 1 μg/ml
CD28 (clone CD28.2, BD Biosciences) mabs. For some ex-
periments, cells were stimulated with 100 ng/ml recombin-
ant IL2 (Biolegend) or soluble CD3 mab alone for 24 hrs
with or without brefeldin (GolgiPlug, BD Biosciences).
Flow cytometry
At appropriate time points, memory CD4 and memory
CD8 T cells were examined for activation (surface and
intracellular CD69) and intracellular GrzB expression by
flow cytometry. Cells were washed with PBS/2%FBS and
incubated with CD69-APC or -PE mabs (Biolegend and
R&D Systems) for 30 mins at 4°C. Cells were then washed
and fixed and permeabilized with Cytofix/Cytoperm solu-
tion (BD Biosciences) for 30 mins at 4°C. After fixation,
cells were washed with Perm/Wash solution (BD Biosci-
ences), then incubated with GrzB-AlexaFluor-700, -PE,
or –APC mabs (BD Biosciences and Invitrogen) for 30
mins at 4°C. Cells were washed and analyzed with flow
cytometer. Cells were also stained with appropriate
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acquired with Gallios Flow Cytometer and analyzed
with Kaluza1.2 software (Beckman-Coulter). For meas-
urement of CD107a coexpression with GrzB, CD107a-
FITC (BD Biosciences) was added to cells at the start of
the experiment. Cells were then cultured with brefeldin
for 3-4 hrs. Cells were then harvested and stained for
GrzB as described above. For measurement of intracel-
lular perforin expression with GrzB, cells (memory T
cells and NK cells) were fixed/permeabilized with
Cytofix/Cytoperm solutions, and stained with perforin-
PE (eBioscience) and GrzB-APC mabs. For measure-
ment of intracellular cytokine expression with GrzB,
memory T cells were fixed/permeabilized with Cytofix/
Cytoperm solutions, and stained with GrzB-PE and ei-
ther IFNγ-FITC, IL4-FITC, or IL17A-Pacific blue mabs
(Biolegend and eBioscience). For measurement of GrzB ex-
pression by Tregs, memory CD4 T cells were stained using
Foxp3 fixation/permeabilization solutions (eBiocience) and
CD25-V450 (BD Biosciences), Foxp3-PE (eBioscience), and
GrzB-APC.
ELISpot
GrzB ELISpot’s were performed in accordance with manu-
facturer instructions (Mabtech). 1×105 memory CD4 and
memory CD8 T cells were cultured (200 μl/well) for
24 hrs in 96-well flat-bottomed nitrocellulose plates
(MultiScreen-HTS, Millipore). Wells were first pre-
pared by treating with 70% ethanol for 2 mins and
rinsing with sterile H20. Wells were then coated over-
night at 4°C with 15 μg/ml GrzB mab (clone GB10).
After GB10 coating, wells were washed with PBS, and
pre-incubated with cell culture RPMI-1640 medium
(200 μl/well) for 30 mins at room temp. Cells were
then added to appropriate wells and either unstimu-
lated (UT) or costimulated with 1 μg/ml soluble CD3
(clone CD3-2, Mabtech) + soluble CD28 mabs (clone
CD28.2, BD Biosciences) for 48 hrs wrapped in
aluminum foil at 37°C + 5%CO2. After the treatment
period, cells were gently harvested for flow cytometry
staining, and wells were washed with PBS. 1 μg/ml bi-
otinylated GrzB detection mabs (clone GB11) were
added for 2 hrs at room temp. Wells were washed and
streptavidin-HRP added for 1 hr. Wells were washed
and TMB substrate added until spot development (10-
30 mins). Color development was stopped with H20,
and plates were air-dried, wrapped, and stored at room
temp. until spot analysis. Spots were analyzed using
CTL-ImmunoSpot S4 analyzer (Cellular Technology
Limited).
ELISA
At appropriate time points, culture supernatants were
harvested, spun free of cells, and frozen at -20°C forextracellular GrzB or perforin measurements by sand-
wich ELISA kit (Mabtech). GrzB ELISA was performed
according to manufacturer instructions. MaxiSorp flat-
bottom 96-well plates (Nunc) were first coated with
2 μg/ml GrzB mab (clone GB10) overnight at 4°C. Wells
were then washed 2x with PBS, then blocked for 1 hr at
room temperature with PBS/0.05%Tween-20/0.1%BSA.
Samples were added for 2 hrs at room temp., wells
washed, then 1 μg/ml GrzB-biotin (clone GB11) added
for 1 hr. Wells were then washed, and 1 μg/ml
streptavidin-HRP added for 1 hr. After streptavidin-HRP
incubation, wells were washed and TMB substrate added
for up to 20 mins (Biolegend). Color development was
stopped with TMB stop solution and OD (450 nm ab-
sorbance) measured with plate reader (Tecan Sunrise).
Sample concentrations were determined with standard
curve (range of 23-2,000 pg/ml) after blank subtraction.
For measurement of extracellular perforin, an ELISA
kit was used in accordance with manufacturer instruc-
tions (Mabtech). Samples were added to perforin mab-
precoated plates for 2 hrs. Wells were then washed and
detection mab added for 60 mins. Wells were washed
and Streptavidin-HRP added for 60 mins. Wells were
washed and TMB substrate added for 15 mins, followed
by addition of stop solution. OD was measured at 450
nm absorbance and concentrations determined with
standard curve (range of 36-10,000 pg/ml).
Statistics
The values were presented by mean and standard error.
Wilcoxon signed-rank tests were used to compare the
difference between untreated and costimulated condi-
tions, and between CD4 and CD8 cells for each assay,
respectively. The Spearman correlation coefficients were
used to assess the correlation among continuous vari-
ables. A p-value <0.05 was considered statistically signifi-
cant. SAS software version 9.3 (SAS Institute, Cary, NC)
was used for analyses.
Results and discussion
Differential storage and secretion of granzyme B between
memory CD4 and memory CD8 T cells
Both memory CD4 and CD8 T cells express GrzB and
utilize GrzB for CTL functions. The use of flow cytome-
try for measurement of GrzB, perforin, or CD107a sug-
gests that CD8 T cells produce more GrzB and may be
more potent CTL effectors than CD4 T cells [11-13].
However, murine CTL lysis assays show that CD4 and
CD8 T cells kill target cells with similar efficacy, indicat-
ing lack of correlation between intracellular GrzB ex-
pression and extracellular GrzB secretion by CD4 and
CD8 T cells [14]. To further clarify these differences, we
directly compared resting or activated (24 hrs CD3/
CD28 costimulation) 1×105 (cultured in 200 μl medium)
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+CD45RO+ T cells from the same donor using in paral-
lel multiparameter flow cytometry, ELISpot, and ELISA.
Multiparameter flow cytometry measures intracellular
GrzB protein which can be examined in conjunction
with other cellular markers, ELISpot measures individual
GrzB-secreting cells, and ELISA measures total amounts
of GrzB released by cells in a specified volume.
Measurement of intracellular GrzB by flow cytometry
showed that resting and activated memory CD8 T cells
stored significantly more GrzB compared to memory
CD4 T cells (Figure 1A). Resting memory CD8 T cells
expressed 25.2 ± 4.7% intracellular GrzB protein, which
did not significantly increase after 24 hrs costimulation to
29.0 ± 3.3% (p = 0.38, n = 10). Resting memory CD4 T cells
expressed little to no intracellular GrzB (2.8 ± 0.5%), but
GrzB expression was significantly increased by costimula-
tion to 8.9 ± 1.9% (p = 0.0002, n = 13). Additionally, resting
and activated memory CD8 T cells expressed significantly
more intracellular GrzB compared to resting and activated
memory CD4 T cells (p = 0.002). These data corroborate
previous reports of intracellular GrzB protein measure-
ments by flow cytometry or western blot showing higher
expression by CD8 compared to CD4 T cells [11-15]. How-
ever, unlike memory CD8 T cells, GrzB synthesis is actually
upregulated by memory CD4 T cells during T cell activa-
tion. These data suggest that activated memory CD8 Tcells
secrete pre-synthesized GrzB (stored in lysosomes) directly
from granules, whereas activated memory CD4 T cells se-
crete pre-stored and newly synthesized GrzB. This GrzB
synthesis step by memory CD4 T cells may also be consist-
ent with a previously reported observation of a less rapid,
but ultimately comparable, CTL activity (target cell lysis in
a 6 hrs assay) by antigen-specific CD4 T cells compared to
CD8 T cells in a murine model of LCMV infection [14].
Although the use of ELISpot to examine GrzB release
by CD8 T cells is well-described [16-20], less clear is
how well this method measures GrzB release by memory
CD4 T cells. By contrast to flow cytometry data, meas-
urement of secreted GrzB with ELISpot showed that the
number of GrzB-secreting cells was comparable be-
tween activated memory CD4 and memory CD8 T cells
(Figure 1B). ELISpot assays showed that resting mem-
ory CD4 T cells did not secrete GrzB after 24 hrs cul-
ture. However, some resting memory CD8 T cells
constitutively secreted GrzB (~60 GrzB spots per 1×105
resting memory CD8 T cells), consistent with more stor-
age of GrzB and low levels of stimulation in vitro. After 24
hrs costimulation, similar numbers of GrzB spots were de-
tected by activated memory CD4 (171 ± 46 GrzB spots per
1×105 memory CD4 T cells, n = 13) and memory CD8 T
cells (205 ± 38 GrzB spots per 1×105 memory CD8 T cells,
n = 10, p = 0.11). Although ELISpot sensitivity may more
be limited beyond a particular range of spot formation,these data suggest that similar numbers of activated mem-
ory CD4 and memory CD8 T cells secreted GrzB.
Consistent with the ELISpot assays, measurement of
bulk supernatant GrzB by ELISA showed that activated
memory CD4 and memory CD8 T cells secrete similar
amounts of GrzB (Figure 1C). Extracellular GrzB was
not detected by resting memory CD4 T cells after 24 hrs
culture, but ~30 pg/ml GrzB was detected by resting
memory CD8 T cells. After 24 hrs costimulation, extra-
cellular GrzB was 1,093 ± 476 pg/ml and 627 ± 206 pg/ml
for activated memory CD4 and memory CD8 T cells, re-
spectively. In conjunction with the ELISpot data, these
ELISA data indicate that at a single cell level, similar
amounts of GrzB are secreted per activated memory CD4
(1,093 pg/ml GrzB per 171 cells) and memory CD8 (627
pg/ml GrzB per 205 cells) T cell. These extracellular GrzB
data may also suggest that much of the pre-stored intra-
cellular GrzB in memory CD8 T cells indicated by flow cy-
tometry may not actually be secreted. These similarities of
extracellular GrzB production between memory CD4 and
CD8 T cells are consistent with previous reports of GrzB
effector function demonstrating comparable CTL activity
by CD4 and CD8 T cells using in vitro-generated
virus-specific human CTL clones [13], and in vivo
LCMV-specific CTL assays with mice [14]. Thus, the
simultaneous use of these intracellular and extracellu-
lar GrzB measurements confirm that resting memory
CD8 T cells store more GrzB compared to memory
CD4 T cells. However, similar numbers of activated
memory CD4 T cells secrete similar amounts of GrzB
as memory CD8 T cells, which are likely achieved by
higher levels of de novo GrzB synthesis.
Memory T cell granzyme B assay correlations, and lack of
correlation of GrzB production between memory CD4 and
memory CD8 T cells within single donors
We examined correlations between each GrzB assay for
memory CD4 or memory CD8 T cells (Figure 2A-F).
Inter-assay correlations of GrzB measurement between
flow cytometry, ELISpot, and ELISA suggested that
intracellular GrzB measured by flow cytometry corre-
lates with extracellular GrzB as measured by ELISpot
and ELISA for memory CD4 T cells, but not for memory
CD8 T cells. For memory CD4 T cells, the Spearman
correlation coefficient between GrzB flow cytometry
and ELISA was r = 0.69 (p < 0.0001, n = 26), and r = 0.77
(p < 0.0001) between GrzB flow cytometry and ELISpot
(Figure 2A-B). However, because memory CD8 T cells
store more intracellular GrzB compared to memory
CD4 T cells without proportionally secreting higher
amounts of GrzB, no correlation was observed between
GrzB flow cytometry and ELISA (r = 0.044, p = 0.85,
n = 20), or between GrzB flow cytometry and ELISpot
(r = 0.23, p = 0.34) (Figure 2D-E). Additionally, these
Figure 1 Comparison of intracellular and extracellular GrzB protein levels by memory CD4 and memory CD8 T cells. (A) Representative
flow cytometry dotplots and mean ± sem intracellular GrzB protein expression by 1×105 untreated (UT) or activated (CD3/CD28 costimulation)
memory T cells after 24 hrs culture (n = 10-13). (B) Representative ELISpot wells and mean ± sem GrzB spots (per 1×105 cells) of untreated or
activated (CD3/CD28 costimulation) memory T cells after 24 hrs culture (n = 10-13). (C) Extracellular GrzB production (ELISA) by 1×105 untreated
or activated (CD3/CD28 costimulation) memory T cells after 24 hrs culture (mean ± sem, n = 10-13).



























































































































































Memory CD4 GrzB assay correlations
Memory CD8 GrzB assay correlations













































































Intra-Donor Memory CD4 vs. Memory CD8 GrzB correlations
Figure 2 Inter-assay correlations between intracellular and extracellular GrzB assays of memory T cells, and intra-donor correlations of
GrzB production between memory T cells. (A-F) Spearman correlations between intracellular (flow cytometry) and extracellular (ELISA and
ELISpot) GrzB measurements of 1×105 untreated (UT) or activated (CD3/CD28 costimulation) memory CD4 (A-C) or memory CD8 (D-F) T cells
(n = 20-26). (G-I) Spearman correlations comparing GrzB production (costimulation values) of memory CD4 vs. memory CD8 T cells within single
donors as measured by flow cytometry, ELISpot, or ELISA (n = 9-10).
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lar GrzB of memory CD8 T cells are unlike those for
cytokines such as IFNγ or IL2 which strongly correlate
between intracellular and extracellular levels for CD4
and CD8 T cells. For example, human resting T cells do
not express or pre-store intracellular IFNγ or IL2 (mea-
sured by flow cytometry), but upregulate these cyto-
kines intracellularly and extracellularly (measured by
ELISpot or ELISA) upon T cell activation, and cytokine
detection between flow cytometry and either ELISpot
or ELISA significantly correlate (r = 0.6-0.9) [21-26].
Since memory CD4 T cells do not pre-store GrzB at
levels similar to memory CD8 T cells, these inter-assay
correlations between intracellular and extracellular
GrzB of memory CD4 T cells resemble the correlations
of other secreted factors that are not pre-stored, such as
cytokines. Lastly, the correlation between GrzB ELISpot
and ELISA was comparable for memory CD4 (r = 0.80,
p < 0.0001, Figure 2C) and memory CD8 (r = 0.80, p <
0.0001, Figure 2F) T cells. Thus, the correlation between
intracellular and extracellular GrzB is stronger for mem-
ory CD4 T cells compared to memory CD8 T cells.
The bulk data in Figure 1 suggests that intracellular
GrzB is increased by activated memory CD4 but not by
memory CD8 T cells (Figure 1A), whereas extracellular
GrzB is increased by both activated memory CD4 and
memory CD8 T cells (Figure 1B-C). However, when we
examined GrzB production by memory CD4 and mem-
ory CD8 T cells within individual donors to determine if
increased GrzB production by memory CD4 T cells is
also associated with increased GrzB production by mem-
ory CD8 T cells, and vice versa (ie. if GrzB production
capacity is inherent to a person or to memory T cell sub-
sets), correlations of GrzB production between memory
CD4 and memory CD8 T cells from the same donor
were weak (r < 0.50, Figure 2G-I). Spearman correlations of
intracellular and extracellular GrzB production (costimula-
tion values) also indicated that no significant correlations
exist between memory CD4 and memory CD8 T cells for
any assay (p = 0.14-0.22). The use of GrzB absolute or per-
cent changes (change from UT to costimulation) also
yielded no significant correlations between memory CD4
and memory CD8 T cells for each assay (data not shown).
Although Figure 1 shows that GrzB production by memory
T cells is generally increased by T cell activation, these data
in Figure 2 suggest that within an individual, the induction
and secretion levels of GrzB are different and unique be-
tween memory CD4 and memory CD8 T cells.
Association of CD107a degranulation marker with
extracellular, but not intracellular, granzyme B of memory
T cells
We examined the association of memory T cell GrzB
with activation and degranulation markers, which moreaccurately indicates GrzB-expressing cells that are also
actively secreting GrzB. CD69 is an early T cell activa-
tion marker that is transiently upregulated by activated
T cells, and CD107a (LAMP-1) is a lysosomal protein
detectable by flow cytometry surface staining after tran-
sient lysosomal fusion to the cellular membrane and re-
lease of granule proteins during T cell activation. Surface
expression of CD107a is also associated with perforin re-
lease by human CD8 T cells, and correlates with CTL ef-
fector function [18,27]. After 24 hrs costimulation, total
CD69 expression by memory CD4 (~47%) and memory
CD8 (~40%) T cells were similar (Figure 3B). If gated on
total memory CD4 or memory CD8 T cells, CD69 coex-
pression with GrzB (CD69+/GrzB+) was higher by acti-
vated memory CD8 (15.5 ± 1.9%) compared to memory
CD4 (5.9 ± 1.2%, p = 0.001, n = 16-17) T cells (Figure 3C).
However, out of the GrzB+memory CD4 or memory
CD8 T cells, CD69 expression was higher by memory
CD4 (75.8 ± 4.1%) compared to memory CD8 T cells
(56.2 ± 4.9%, p < 0.01, Figure 3D), indicating that more
GrzB-expressing memory CD4 T cells are also activated
compared to memory CD8 T cells.
After 24 hrs costimulation, total CD107a expression
was 9.2 ± 2.9% in activated memory CD4, and 15.6 ±
2.9% in memory CD8 T cells (p = 0.15, n = 6, Figure 3F).
If gated on total memory CD4 or memory CD8 T cells,
CD107a+/GrzB+ coexpression was 1.5 ± 0.4% by mem-
ory CD4, but higher at 5.9 ± 1.3% by memory CD8 T
cells (p = 0.03, Figure 3G), which may more accurately
corroborate the frequency of less than 1% activated
memory T cells that secrete GrzB as indicated by ELI-
Spot in Figure 1B. But unlike the difference of CD69 ex-
pression (out of GrzB-expressing memory T cells) between
activated memory T cells shown in Figure 3D, CD107a
expression by activated GrzB+ memory T cells was
similar (Figure 3H). Additionally, the parallel extracel-
lular GrzB levels (ELISA) for these experiments were
similar between activated memory T cells (Figure 3I),
suggesting that CD107a is more accurate than CD69 as
an indicator of GrzB secretion by activated memory T
cells. For memory CD4 T cells, the Spearman correl-
ation of CD107a with intracellular GrzB was r = 0.035
(p = 0.91, n = 12), and r = 0.69 (p = 0.058, n = 8) with
extracellular GrzB (Figure 3J). Similarly for memory
CD8 T cells, the correlation of CD107a with intracellu-
lar GrzB was r = -0.02 (p = 0.53), and r = 0.71 (p = 0.05)
with extracellular GrzB (Figure 3K). Despite increased
surface expression of CD107a and release of GrzB by
activated memory CD8 T cells (compared to UT), intra-
cellular GrzB of memory CD8 T cells does not signifi-
cantly change after activation as shown by flow
cytometry in Figure 1A, which may be consistent with
an earlier report that demonstrates by flow cytometry
that increased surface expression of CD107a and
Figure 3 (See legend on next page.)
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Figure 3 Association of memory T cell GrzB secretion with activation and degranulation markers. (A-D) Memory T cell flow cytometry
dotplots and mean ± sem (n = 16-17) total surface CD69 expression or CD69+/GrzB+ coexpression (gated on total memory CD4 or memory CD8
T cells), or CD69 expression gated on GrzB+memory CD4 or memory CD8 T cells. (E-H) Flow cytometry dotplots and mean ± sem (n = 6) total
surface CD107a expression or CD107a+/GrzB+ coexpression (gated on total memory CD4 or memory CD8 T cells), or CD107a expression gated on
GrzB+memory CD4 or memory CD8 T cells. (I) GrzB ELISA of memory T cells conducted in parallel with CD107a experiments. (J-K) Spearman
correlations between CD107a and intracellular (flow cytometry) or extracellular (ELISA) GrzB of memory T cells (n = 8-12).
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of intracellular perforin [27]. For memory CD4 T
cells, both CD107a and intracellular GrzB are associ-
ated with GrzB secretion to similar degrees, and in-
creased surface expression of CD69 and CD107a by
activated memory CD4 T cells is further associated
with the increased intracellular GrzB expression
shown by flow cytometry in Figure 1A. These data fur-
ther corroborate Figure 1, in which activated memory
CD8 T cells secrete GrzB mainly from pre-stored granules,
whereas GrzB secretion by memory CD4 T cells is likely
derived from pre-stored and newly synthesized GrzB to
achieve the similar extracellular GrzB levels. Despite
higher intracellular storage of GrzB by activated memory
CD8 compared to memory CD4 T cells (as shown by flow
cytometry in Figure 1A), CD107a expression by activated
GrzB+memory T cells, as well as the number of GrzB-
secreting cells (as indicated by ELISpot in Figure 1B), were
similar. This may suggest that a higher proportion of acti-
vated GrzB+memory CD4 T cells secrete and deplete
their GrzB stores. This contrasts with higher retention of
intracellular GrzB by activated memory CD8 T cells, since
ELISpot numbers would be substantially higher if all acti-
vated CD8 T cells released their intracellular GrzB stores.
These differences may allow memory CD8 T cells to be
more sustained serial killers of target cells, whereas mem-
ory CD4 T cells may express GrzB for shorter-term func-
tions [28-30].
Less association of granzyme B with perforin by memory
CD4 T cells compared to memory CD8 and natural killer cells
We next examined GrzB production by memory T cells
in conjunction with perforin, and also in comparison
with natural killer (NK) cells, abundant producers of
GrzB and perforin. In addition to GrzB, CD4 T cells ex-
press perforin to eliminate target cells [8,31,32]. Memory
CD4+CD45RO+ and memory CD8+CD45RO+ T cells,
and CD56+ NK cells, were purified from peripheral
blood of the same donor and cultured in parallel, with
or without the intracellular protein transport inhibitor
brefeldin. Memory T cells and NK cells (5×105 cells in 1
ml medium) were stimulated for 24 hrs with IL2 (100
ng/ml). Additionally, memory T cells were alternatively
stimulated with soluble anti-CD3 mabs only (1 μg/ml),
as CD28 expression by memory CD8 T cells (~80%) wasmodestly lower compared to memory CD4 T cells
(~95%, data not shown), which may result in memory
CD4 T cells receiving stronger stimulation by CD3/
CD28 costimulation compared to memory CD8 T cells.
Agonism of other costimulatory receptors such as ICOS
or TNF superfamily members may further yield different
results. Intracellular and extracellular perforin and GrzB
were measured by flow cytometry and ELISA.
Figure 4A-B shows representative perforin/GrzB
flow cytometry dotplots (Figure 4A) and the mean
distribution of intracellular perforin/GrzB subpopula-
tions (Figure 4B) for memory T cells and NK cells
(n = 4). For memory CD4 T cells, only perforin-/GrzB+
cells were mainly observed in all conditions (~4-6%, with
and without brefeldin), and a small percentage of perforin
+/GrzB+ cells were observed by IL2 stimulation (1.3 ±
0.6%, without brefeldin). However, memory CD8 T cells
expressed more intracellular perforin and GrzB. In the ab-
sence of brefeldin, UT memory CD8 T cells were 1.1 ±
0.9% perforin+/GrzB-, 25.5 ± 1.5% perforin-/GrzB+, and
2.6 ± 1.3% perforin+/GrzB+. IL2 stimulation changed these
perforin/GrzB distributions by increasing perforin expres-
sion (10.0 ± 6.5% perforin+/GrzB-, and 15.9 ± 7.3% per-
forin+/GrzB+), whereas CD3 stimulation did not affect the
perforin/GrzB expression patterns. In the presence of bre-
feldin, perforin expression was mitigated and memory CD8
T cells were mostly perforin-/GrzB+ (~28% for all condi-
tions). As expected, intracellular perforin and GrzB ex-
pression was substantially higher for NK cells compared
to memory T cells. In the absence of brefeldin, NK cells
were mostly perforin+/GrzB+ (UT NK cells were 14.1 ±
4.0% perforin-/GrzB+ and 66.1 ± 7.3% perforin+/GrzB+,
and IL2-stimulated cells were 11.9 ± 3.2% perforin-/GrzB
+ and 80.7 ± 6.1% perforin+/GrzB+), by contrast to mem-
ory T cells which were mostly perforin-/GrzB+. But in the
presence of brefeldin, this distribution changed to mostly
perforin-/GrzB+ (59.3 ± 12.1% perforin-/GrzB+ and 18.9
± 10.5% perforin+/GrzB+ by UT cells, and 51.6 ± 17.5%
perforin-/GrzB+ and 32.5 ± 18.4% perforin+/GrzB+ by
IL2-stimulated cells), which was similar to the perforin
mitigation by brefeldin of memory CD8 T cells. Thus,
intracellular perforin is marginally expressed with GrzB by
stimulated memory CD4 T cells, whereas perforin is more
associated with GrzB in memory CD8 T cells and NK
cells.
Figure 4 (See legend on next page.)
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Figure 4 Comparison of GrzB and perforin expression between memory CD4, memory CD8, and natural killer cells. (A) Representative
GrzB/perforin dotplots of memory CD4, memory CD8, and NK cells. Cells were purified from peripheral blood, and 5×105 cells (in 1 ml medium)
were untreated (UT) or stimulated with IL2 (100 ng/ml) or anti-CD3 only mabs (1 μg/ml) for 24 hrs +/- brefeldin. (B) Mean (n = 4) distribution of
perforin/GrzB subsets of memory CD4, memory CD8, and NK cells. (C-D) Extracellular GrzB and perforin production by memory CD4, memory
CD8, and NK cells after 24 hrs culture +/- brefeldin (mean ± sem, n = 3-4, ap < 0.05 comparing UT NK cells to UT memory CD4 and memory CD8
T cells, bp < 0.05 comparing IL2-treated NK cells to IL2-treated memory CD4 and memory CD8 T cells, cp < 0.05 comparing UT or IL2-treated NK
cells to UT or IL2-treated memory CD4 T cells).
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by memory CD4 T cells, perforin was secreted with
GrzB by stimulated memory CD4 T cells as deter-
mined by ELISA, but in a pattern distinct from mem-
ory CD8 T cells (Figure 4C-D). In the absence of
brefeldin, IL2- and CD3-stimulated memory CD4 T
cells released 1,950 ± 549 pg/ml and 336 ± 108 pg/ml
GrzB, respectively, more than memory CD8 T cells
which released 249 ± 58 pg/ml and 86 ± 26 pg/ml
GrzB (p < 0.05). However, UT and IL2-stimulated
memory CD8 T cells released 372 ± 71 pg/ml and
1,304 ± 284 pg/ml perforin, which was more than
memory CD4 T cells which released 159 ± 20 pg/ml
and 521 ± 108 pg/ml perforin (p < 0.05). Perforin re-
lease by CD3-stimulated memory T cells was similar
(385 ± 106 pg/ml by memory CD4, and 415 ± 89 pg/
ml by memory CD8 T cells). As expected, UT and
IL2-stimulated NK cells secreted substantially more
perforin (977 pg/ml by UT and 6,029 pg/ml by IL2-
stimulated cells) and GrzB (119 pg/ml by UT and
8,475 pg/ml by IL2-stimulated cells) compared to
memory T cells in the absence of brefeldin (p < 0.05).
In the presence of brefeldin, perforin and GrzB re-
lease by stimulated memory T cells was reduced
nearly to baseline (UT) levels, and reduced ~2-3 fold
by NK cells. An unclear effect of brefeldin upon rest-
ing memory T cells and NK cells was observed, in
which a modest decrease of constitutive perforin re-
lease, but an increase of GrzB release, by UT memory
T cells and NK cells occurred. It is possible that
intracellular storage of GrzB may be more disasso-
ciated with perforin by resting T cells and NK cells
compared to activated states. Additionally, IL2-
stimulated memory CD4 T cells and NK cells appear
to secrete more GrzB than perforin, whereas memory
CD8 T cells secrete more perforin than GrzB. Lastly,
despite the release of perforin and GrzB by stimulated
memory T cells and NK cells (as shown by ELISA),
intracellular accumulation (or increased intracellular
expression) of perforin and GrzB in stimulated cells
did not occur in the presence of brefeldin (compared
to stimulated cells in the absence of brefeldin). This
is likely due to glycosylation requirements of perforin
and GrzB for intracellular transport and secretion
[33,34], which would be inhibited by brefeldin.Memory CD4 T cells with granzyme B production capacity
include Tregs and Th1 cells, with potentially more distinct
GrzB vs. cytokine secretory mechanisms compared to CD8
T cells
We lastly examined memory CD4 T cell subsets that
produce GrzB such as Treg, Th1, Th2, and Th17 cells.
Memory CD4+CD45RO+ T cells were purified from
peripheral blood and activated (CD3/CD28 costimula-
tion or PMA/IO in the presence of brefeldin) or UT for
24 hrs. Cells were then analyzed by flow cytometry for
phenotype (CD25-high and Foxp3 for Tregs) and func-
tion (intracellular cytokines - IFNγ for Th1, IL4 for Th2,
and IL17A for Th17 cells) in conjunction with GrzB
expression.
24 hrs costimulation or PMA/IO treatment of memory
CD4 T cells resulted in GrzB expression by phenotypes
consistent with Treg and Th1 cells (Figure 5A-C). Tregs
were examined by measuring intracellular GrzB expression
by CD25+/Foxp3+ costimulated memory CD4 T cells. Ac-
tivated memory CD4 T cells expressed ~18% CD25 (13%
CD25-Dim and 4.6% CD25-Bright, Figure 5A). GrzB was
coexpressed with Foxp3 by CD25-Dim cells (24.2 ± 3.6%
Foxp3+/GrzB-, 4.6 ± 1.0% Foxp3-/GrzB+, and 1.4 ± 0.4%
Foxp3+/GrzB+), and more so by CD25-Bright cells (52.5 ±
4.0% Foxp3+/GrzB-, 4.8 ± 0.8% Foxp3-/GrzB+, and 4.3 ±
0.6% Foxp3+/GrzB+, Figure 5B). This is consistent with re-
ports that demonstrate Treg expression of GrzB for sup-
pressive functions [35-37]. IFNγ was modestly induced
and coexpressed with GrzB by costimulated memory
CD4 T cells (0.3 ± 0.1% IFNγ+/GrzB- and 0.5 ± 0.3%
IFNγ+/GrzB+), but more robustly by PMA/IO treat-
ment (29.6 ± 3.4% IFNγ+/GrzB- and 2.4 ± 0.8% IFNγ+/
GrzB+, Figure 5C), indicating that memory CD4 Th1 cells
express GrzB, consistent with other reports [38-41]. By
contrast, IL4 was not induced by costimulated or PMA/
IO-treated memory CD4 T cells (0.1% IL4+/GrzB+), sug-
gesting that GrzB is not expressed by memory CD4 Th2
cells. IL17A was induced by costimulation and PMA/IO,
but not coexpresssed with GrzB (0.1% IL17A+/GrzB+),
suggesting that in these short-term conditions memory
CD4 Th17 cells may not express GrzB. Th17 cells are re-
ported to express GrzB in vivo [42,43], which likely in-
volves more complex stimuli, timing or differentiation,
and more specific phenotypic characterization (ie. CCR6,
CD161, and IL-23R). Thus, Tregs and Th1 cells are
Figure 5 (See legend on next page.)
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Figure 5 GrzB production by memory CD4 T cell subsets and coexpression with cytokines. (A-B) GrzB expression by Tregs. Memory CD4 T
cells were purified from peripheral blood, and 5×105 cells (in 1ml medium) were untreated (UT) or activated (CD3/CD28 costimulation) for 24 hrs.
Cells were then stained for CD25, Foxp3, and GrzB. (A) CD25 expression levels (Negative, Dim, or Bright) by memory CD4 T cells after 24 hrs
culture (mean ± sem, n = 3). (B) Foxp3/GrzB expression by CD25-Negative, CD25-Dim, or CD25-Bright memory CD4 T cells after 24 hrs culture.
Graph shows the mean (n = 3) distribution of Foxp3/GrzB subsets gated on CD25-Negative, -Dim, or -Bright cells. (C) GrzB coexpression with IFNγ,
IL4, or IL17A by memory CD4 T cells. Memory CD4 T cells (5×105 cells in 1ml medium) were untreated for activated (CD3/CD28 costimulation or
PMA/IO in the presence of brefeldin) for 24 hrs, then stained for GrzB and either IFNγ, IL4, or IL17A. Graphs show the mean (n = 3) distribution of
cytokine/GrzB subsets. (D) GrzB/IFNγ coexpression by memory CD8 T cells. Purified memory CD8 T cells (5×105 cells in 1 ml medium) were
untreated or activated (CD3/CD28 costimulation or PMA/IO in the presence of brefeldin) for 24 hrs. Graph shows the mean (n = 3) distribution of
IFNγ/GrzB subsets.
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duce GrzB in the present study, although other GrzB-
producing subsets, particularly CD4 CTL’s, are likely in-
volved as well [8-10,14].
For comparison of cytokine/GrzB coexpression by
memory CD4 Th1 cells, purified memory CD8+CD45RO+
T cells were examined for IFNγ and GrzB coexpression as
well (Figure 5D). Compared to CD8 T cells or NK cells,
cytokine secretion pathways of CD4 T cells may be more
diversified and distinct from those of cytotoxic mediators
such as granzymes [44]. For example, in activated murine
CD4 T cells, IL2 and IFNγ colocalize and are secreted by a
more polarized mechanism compared to other secreted
mediators such as TNFα and chemokines [45]. Addition-
ally in NK cells, IFNγ and TNFα are stored and packaged
in vesicles distinct from perforin-containing granules,
and secreted in a more nonpolarized fashion compared
to perforin [46]. In the present study, 24 hrs CD3/
CD28 costimulation of memory CD8 T cells induced
3.8 ± 1.5% IFNγ+/GrzB- and 3.7 ± 2.0% IFNγ+/GrzB+
expression, and PMA/IO treatment induced 40.1 ± 5.3%
IFNγ+/GrzB- and 19.3 ± 5.9% IFNγ+/GrzB+ expression.
Thus, compared to PMA/IO-treated memory CD4 T
cells (~3% IFNγ+/GrzB+), IFNγ+/GrzB+ expression by
PMA/IO-treated memory CD8 T cells was significantly
higher (p < 0.05), suggesting that cytokine, as well as
perforin, secretion pathways of memory CD4 T cells
may be more disassociated with GrzB secretion com-
pared to memory CD8 T cells. These differences may
be relevant to the weak correlations of GrzB expression
and secretion between memory CD4 and memory CD8
T cells within single donors shown in Figure 2G-I.
Conclusions
In the present study, GrzB expression and secretion was
directly compared between human memory CD4 and
memory CD8 T cells using flow cytometry, ELISpot, and
ELISA. The results show that memory CD8 T cells store
more GrzB, but do not secrete more GrzB, compared to
memory CD4 T cells during short-term activation, sug-
gesting that activated CD8 T cells regulate their GrzB
release more than CD4 T cells. Consequently, the correl-
ation between intracellular and extracellular GrzB formemory CD8 T cells is weaker compared to memory
CD4 T cells. Additionally, CD107a is a better indicator
of GrzB secretion by memory T cells than intracellular
GrzB itself. These results corroborate and further clarify
previous studies examining GrzB production by human
or mouse CD4 and CD8 T cells, which utilized either
flow cytometry, ELISpot, or ELISA, but not all three
methods simultaneously. Distinct patterns of GrzB pro-
duction between memory T cells may further be due to
different associations with other secreted factors such as
perforin or cytokines.
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